Sentiment-Signal
14,3
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Unternehmen & Branche
| Name | Disc Medicine, Inc. |
|---|---|
| Ticker | IRON |
| CIK | 0001816736 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 2,53 Mrd. USD |
| Beta | 2,54 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -212,184,000 | -6.01 | 806,879,000 | 739,826,000 | |
| 2025-09-30 | 10-Q | -62,321,000 | -1.77 | 630,456,000 | 573,391,000 | |
| 2025-06-30 | 10-Q | -55,247,000 | -1.58 | 665,061,000 | 614,165,000 | |
| 2025-03-31 | 10-Q | -34,085,000 | -1.02 | 709,266,000 | 660,362,000 | |
| 2024-12-31 | 10-K | -109,357,000 | -3.96 | 496,773,000 | 443,587,000 | |
| 2024-09-30 | 10-Q | -26,599,000 | -0.89 | 495,145,000 | 467,960,000 | |
| 2024-06-30 | 10-Q | -26,352,000 | -1.03 | 510,217,000 | 488,829,000 | |
| 2024-03-31 | 10-Q | -26,949,000 | -1.09 | 354,182,000 | 338,071,000 | |
| 2023-12-31 | 10-K | -76,429,000 | -3.42 | 367,996,000 | 345,121,000 | |
| 2023-09-30 | 10-Q | -14,122,000 | -0.58 | 376,497,000 | 358,974,000 | |
| 2023-06-30 | 10-Q | -15,947,000 | -0.74 | 384,174,000 | 371,219,000 | |
| 2023-03-31 | 10-Q | -22,781,000 | -1.20 | 243,780,000 | 232,855,000 | |
| 2022-12-31 | 10-K | -46,827,000 | -45.05 | 200,205,000 | 176,600,000 | |
| 2022-09-30 | 10-Q | -16,150,000 | -16.82 | 106,031,000 | -98,527,000 | |
| 2022-06-30 | 10-Q | -9,580,000 | -10.14 | 113,333,000 | -82,781,000 | |
| 2022-03-31 | 10-Q | -9,853,000 | -10.67 | 124,285,000 | -73,669,000 | |
| 2021-12-31 | 10-K | -35,969,000 | -40.95 | 92,411,000 | -64,203,000 | |
| 2021-09-30 | 10-Q | -18,551,000 | -0.43 | 155,535,000 | 140,861,000 | |
| 2021-06-30 | 10-Q | -16,447,000 | -0.38 | 172,422,000 | 157,682,000 | |
| 2021-03-31 | 10-Q | -19,048,000 | 189,382,000 | 171,161,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-14 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -6,257 | 69.24 | -433,234.05 | -24,7% | |
| 2026-04-13 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -400 | 69.00 | -27,600.00 | -1,6% | |
| 2026-04-13 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -3,531 | 66.12 | -233,472.90 | -13,3% | |
| 2026-04-13 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -2,200 | 66.81 | -146,976.06 | -8,4% | |
| 2026-03-02 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -2,986 | 66.41 | -198,297.27 | -11,3% | |
| 2026-03-02 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -4,392 | 65.52 | -287,771.75 | -16,4% | |
| 2026-02-25 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -353 | 69.06 | -24,377.09 | -1,4% | |
| 2026-02-18 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -3,397 | 65.01 | -220,837.95 | -12,6% | |
| 2026-02-18 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -3,684 | 65.89 | -242,734.71 | -13,8% | |
| 2026-02-17 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -3,256 | 62.86 | -204,672.16 | -11,7% | |
| 2026-02-17 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -4,075 | 62.86 | -256,154.50 | -14,6% | |
| 2026-02-17 | Stephenson Pamela | Officer, Chief Commercial Officer | Open Market Sale | -5,531 | 62.86 | -347,678.66 | -19,8% | |
| 2025-12-17 | Bitterman Kevin | Director | Open Market Sale | -148 | 91.47 | -13,537.56 | -0,8% | |
| 2025-12-17 | Bitterman Kevin | Director | Open Market Sale | -393 | 91.47 | -35,947.71 | -2,0% | |
| 2025-12-17 | Bitterman Kevin | Director | Open Market Sale | -213 | 91.47 | -19,483.11 | -1,1% | |
| 2025-12-15 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -9,151 | 91.44 | -836,724.43 | -47,6% | |
| 2025-12-15 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -300 | 92.23 | -27,669.00 | -1,6% | |
| 2025-12-15 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -3,642 | 90.60 | -329,978.68 | -18,8% | |
| 2025-10-22 | AI DMI LLC | 10% Owner | Open Market Sale | -744,047 | 80.47 | -59,873,462.09 | -3408,4% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -10,094 | 90.66 | -915,122.04 | -52,1% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -450 | 91.88 | -41,346.00 | -2,4% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -1,125 | 84.89 | -95,501.25 | -5,4% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -2,251 | 89.70 | -201,914.70 | -11,5% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -3,000 | 86.13 | -258,390.00 | -14,7% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -5,065 | 87.37 | -442,529.05 | -25,2% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -5,066 | 87.37 | -442,616.42 | -25,2% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -10,095 | 90.66 | -915,212.70 | -52,1% | |
| 2025-10-17 | Bitterman Kevin | Director | Open Market Sale | -13,014 | 88.91 | -1,157,074.74 | -65,9% | |
| 2025-10-16 | Bitterman Kevin | Director | Open Market Sale | -1,425 | 77.11 | -109,881.75 | -6,3% | |
| 2025-10-15 | Bitterman Kevin | Director | Open Market Sale | -19,542 | 77.16 | -1,507,860.72 | -85,8% | |
| 2025-10-15 | Bitterman Kevin | Director | Open Market Sale | -2,618 | 77.76 | -203,575.68 | -11,6% | |
| 2025-10-08 | Bitterman Kevin | Director | Open Market Sale | -12,689 | 71.51 | -907,390.39 | -51,7% | |
| 2025-10-08 | Bitterman Kevin | Director | Open Market Sale | -8,219 | 68.26 | -561,028.94 | -31,9% | |
| 2025-10-08 | Bitterman Kevin | Director | Open Market Sale | -12,386 | 69.31 | -858,473.66 | -48,9% | |
| 2025-10-08 | Bitterman Kevin | Director | Open Market Sale | -25,400 | 70.54 | -1,791,716.00 | -102,0% | |
| 2025-10-08 | Bitterman Kevin | Director | Open Market Sale | -13,267 | 72.39 | -960,398.13 | -54,7% | |
| 2025-10-07 | Bitterman Kevin | Director | Open Market Sale | -11,378 | 68.01 | -773,817.78 | -44,1% | |
| 2025-10-07 | Bitterman Kevin | Director | Open Market Sale | -6,661 | 69.01 | -459,675.61 | -26,2% | |
| 2025-07-17 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -2,031 | 59.00 | -119,829.00 | -6,8% | |
| 2025-07-10 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -2,000 | 57.50 | -115,000.00 | -6,5% | |
| 2025-06-16 | Franchi Jean M. | Officer, Chief Financial Officer | Open Market Sale | -2,000 | 52.26 | -104,518.80 | -5,9% | |
| 2025-06-06 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -2,996 | 50.00 | -149,800.00 | -8,5% | |
| 2025-05-20 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -6,677 | 50.04 | -334,128.43 | -19,0% | |
| 2025-05-02 | Savage William Jacob | Officer, Chief Medical Officer | Open Market Sale | -2,100 | 50.17 | -105,367.08 | -6,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.